Presentation TCT 2013 The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results Presenter: Juan Granada October 27, 2013
Presentation TCT 2013 Status Update on the Randomized Moderate Risk AS Trials: SURTAVI Presenter: Patrick Serruys October 27, 2013
Presentation TCT 2013 Subgroup Analyses: Proceed with Caution Presenter: Eugene Blackstone October 27, 2013
Presentation TCT 2013 Japan-US Zilver Stent Study and Approval: Lessons Learned and Future Options Presenter: Neal Fearnot October 27, 2013
Presentation TCT 2013 Keynote Lecture: A Clinical and Entrepreneurial Vision of Japan-US Synergies and Health Technologies Presenter: Peter Fitzgerald October 27, 2013
Presentation TCT 2013 Strengthening Our National System for Medical Device Postmarket Surveillance Presenter: John Laschinger October 27, 2013
Presentation TCT 2013 Endovascular Management of Popliteal Aneurysms: Tips and Tricks Presenter: Jacques Busquet October 27, 2013
Presentation TCT 2013 Is Normalized Vasoreactivity at and Distal to the Stent Site Likely to Translate into Improved Clinical Outcomes? Presenter: Raimund Erbel October 27, 2013